Skip to main content
Figure 5 | Journal of Translational Medicine

Figure 5

From: Serum dihydroxyacetone kinase peptide m/z 520.3 as predictor of disease severity in patients with compensated chronic hepatitis B

Figure 5

Detection of serum DAK protein in CHB patients. A-1: Serum DAK levels decrease with disease severity among groups classified by fibrosis degrees (S0-S4 subgroups) in 126 CHB patients. A-2: AUROC of DAK protein is 0.678 (S2-4 versus S0-1). A-3: AUROC of DAK protein is 0.652 (S3-4 versus S0-2). B-1: Serum DAK levels decrease with disease severity among groups classified by inflammatory grades (G0-G4 subgroups) in 126 CHB patients. B-2: AUROC of DAK protein is 0.736 (G2-4 versus G0-1). B-3: AUROC of DAK protein is 0.720 (G3-4 versus G0-2).

Back to article page